Raloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti- estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer. Various Raloxifene related compounds or reference standards, listed on this page are needed in pharmaceutical research at the time to product development, ANDA filing or during production to study quality, stability, and genotoxicity study of Raloxifene related products. Synthink is a most trusted source of Raloxifene Degradation Impurities, Raloxifene Genotoxic impurity, Raloxifene Process Impurities, USP related compounds, Raloxifene Nitrosamine impurity, N-Nitroso impurity etc. which are listed on this page.